• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Cipla`s Generics Nicardipine HCl Receives Approval in US

    FDA

    Enforcement Report - Week of May 29, 2024

    FDA

    InfoRLife Generic Nicardipine Hydrochloride Receives Approval In US

    FDA

    SKG Pharma`s Nicardipine Hydrochloride Receives Approval In the US

    FDA

    Enforcement Report - Week of March 27, 2024

    FDA

    Senores announces the launch of Nicardipine Hydrochloride Capsules

    PR NEWSWIRE

    Senores` Generic Nicardipine Hydrochloride Receives Approval in the U.S.

    FDA

    Micro Lab`s Generic Nicardipine Hydrochloride Receives Approval in the U.S.

    FDA

    Square Pharmaceuticals Generic Nicardipine HCL Receives Approval in the U.S

    FDA

    Glenmark Pharma gets USFDA nod for generic drug

    ECONOMIC TIMES

    Glenmark Pharma gets USFDA nod for generic drug

    ECONOMIC TIMES

    Glenmark`s Generic Nicardipine Hydrochloride Receives Approval in the U.S.

    FDA

    Astellas transfers three products in Asia region to Daiichi Sankyo

    BIOSPECTRUM ASIA

    Enforcement Report - Week of May 1, 2019

    FDA

    FDA Singles Out Three Drug Substances to Not be Compounded

    RAPS

    Enforcement Report - Week of February 28, 2018

    FDA

    Mylan recalling two injectable drugs made in India

    FIERCE PHARMA MANUFACTURING

    Mylan Institutional LLC, Ongoing Class III recall of Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10 because of Subpotent Drug and Failed Impurities/Degradation Specifications.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.